Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited

Philippe Gautret (1) , Jean-Christophe Lagier (2) , Stéphane Honoré (3) , van Thuan Hoang (1) , Philippe Colson (2) , Didier Raoult (2)

1 VITROME - Vecteurs - Infections tropicales et méditerranéennes
2 MEPHI - Microbes évolution phylogénie et infections
3 Service Pharmacie [Hôpital de la Timone - APHM]

Domaines: Bactériologie; Virologie; Parasitologie; Cardiologie et système cardiovasculaire; Maladies émergentes; Maladies infectieuses

Philippe Gautret, Jean-Christophe Lagier, Stéphane Honoré, van Thuan Hoang, Philippe Colson, et al.. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. International Journal of Antimicrobial Agents, 2021, 57 (1), pp.106243. ⟨10.1016/j.ijantimicag.2020.106243⟩. ⟨hal-03215698⟩